Q2 2026
Read transcript →BC
Bicara Therapeutics Inc. Common Stock (BCAX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$8.86
+2.43%
Mkt Cap $592.91M
Q1 2026
Read transcript →Q4 2025
Read transcript →NASDAQ·Healthcare·Biotechnology
$8.86
+2.43%
Mkt Cap $592.91M
Q2 2026
Read transcript →Q1 2026
Read transcript →Q4 2025
Read transcript →